Molinalogo

Measure

2024 Rate

2025 Rate

Goal

Effectiveness of Care: Prevention and Screening

Adult Immunization Status (AIS-E) - Influenza (Total)

17.60

17.01

18.61

Adult Immunization Status (AIS-E) - Pneumococcal (66+)

64.59

61.56

58.40

Adult Immunization Status (AIS-E) - Td/Tdap (Total)

55.36

58.61

50.60

Breast Cancer Screening (BCS-E)

48.83

50.45

58.93

Cervical Cancer Screening (CCS) -Total

53.77

53.53

61.52

Childhood Immunization Status (CIS) - Combo 10

29.44

23.60

30.41

Chlamydia Screening in Women (CHL) Total

44.83

43.36

62.81

Immunizations for Adolescents (IMA) - Combination 2

32.60

23.60

40.39

Lead Screening in Children (LSC) -Total

26.03

39.66

74.62

Oral Evaluation, Dental Services (OED) - Total

-

-

49.54

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - BMI percentile (Total)

73.24

77.81

87.69

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - Counseling for Nutrition (Total)

65.45

70.41

77.70

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - Counseling for Physical Activity (Total)

61.80

63.27

75.91

Effectiveness of Care: Respiratory

Asthma Medication Ratio (AMR) -Total

74.60

82.78

68.13

Appropriate Testing for Pharyngitis (CWP) -Total

83.89

87.65

87.31

Pharmacotherapy Management of COPD Exacerbation (PCE) - Bronchodilator

84.15

86.01

86.25

Pharmacotherapy Management of COPD Exacerbation (PCE) -Systemic Corticosteroid

75.38

77.34

74.92

Effectiveness of Care: Cardiovascular

Controlling High Blood Pressure (CBP)

60.83

65.82

70.35

Statin Therapy for Patients With Cardiovascular Disease (SPC) - Received Statin Therapy (Total)

82.50

81.65

82.94

Statin Therapy for Patients With Cardiovascular Disease (SPC) - Statin Adherence 80% (Total)

71.52

72.69

75.45

Effectiveness of Care: Diabetes

Blood Pressure Control for Patients With Diabetes (BPD)

71.05

73.48

74.21

Eye Exam for Patients With Diabetes (EED)

46.96

51.34

60.83

Glycemic Status Assessment for Patients With Diabetes (GSD) - Glycemic Status <8.0%

53.77

58.15

63.04

Glycemic Status Assessment for Patients With Diabetes (GSD) - Glycemic Status >9.0%

37.96

33.58

27.98

Kidney Health Evaluation for Patients With Diabetes (KED) - Total

41.95

43.58

46.17

Statin Therapy for Patients With Diabetes (SPD) - Received Statin Therapy

62.49

63.93

69.01

Statin Therapy for Patients With Diabetes (SPD) - Statin Adherence 80%

69.39

71.11

72.29

Effectiveness of Care: Behavioral Health

Adherence to Antipsychotic Medications for Individuals With Schizophrenia (SAA)

68.04

69.27

69.67

Antidepressant Medication Management (AMM) - Effective Acute Phase Treatment

65.60

66.73

66.99

Antidepressant Medication Management (AMM) - Effective Continuation Phase Treatment

46.71

48.46

49.88

Diabetes Screening for People With Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

81.00

82.19

84.36

Follow-Up After Emergency Department Visit for Mental Illness (FUM) - 30 days (Total)

66.85

64.78

62.41

Follow-Up After Emergency Department Visit for Mental Illness (FUM) - 7 days (Total)

52.12

50.88

46.71

Follow-Up After Emergency Department Visit for Substance Use (FUA) - 30 days (Total)

42.59

44.58

43.24

Follow-Up After Emergency Department Visit for Substance Use (FUA) - 7 days (Total)

27.92

30.54

30.53

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) - 30 days (Total)

62.31

59.81

62.24

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) - 7 days (Total)

43.32

41.43

40.55

Follow-Up After Hospitalization for Mental Illness (FUH) - 30 days (Total)

63.18

66.68

67.40

Follow-Up After Hospitalization for Mental Illness (FUH) - 7 days (Total)

39.75

43.26

45.08

Follow-Up Care for Children Prescribed ADHD Medication (ADD-E) - Initiation Phase

45.76

46.48

49.56

Follow-Up Care for Children Prescribed ADHD Medication (ADD-E) - Continuation and Maintenance Phase

52.41

54.88

58.69

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) - Blood Glucose and Cholesterol Testing (Total)

28.70

29.24

41.52

Effectiveness of Care: Access/Availability of Care

Initiation and Engagement of Substance Use Disorder Treatment (IET) - Initiation of SUD Treatment - Total (Total)

48.97

51.70

49.03

Initiation and Engagement of Substance Use Disorder Treatment (IET) - Engagement of SUD Treatment - Total (Total)

16.05

19.51

17.80

Prenatal and Postpartum Care (PPC) - Timeliness of Prenatal Care

88.56

89.05

88.56

Prenatal and Postpartum Care (PPC) - Postpartum Care

84.67

84.43

83.94

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) - Total

63.18

58.97

82.10